Budget impact of intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency in France

AIMS: This analysis aims to evaluate the budget impact of intravenous iron therapy with ferric carboxymaltose for patients with systolic chronic heart failure and iron deficiency, from the perspective of the French public health insurance. METHODS AND RESULTS: A budget impact model was adapted to fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Bourguignon, Sandrine, Faller, Mathilde, Champs, François‐Olivier, Moutier, Hélène, Levesque, Karine, Caranhac, Gilbert, Cohen‐Solal, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487717/
https://www.ncbi.nlm.nih.gov/pubmed/31021531
http://dx.doi.org/10.1002/ehf2.12432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487717/
https://www.ncbi.nlm.nih.gov/pubmed/31021531
http://dx.doi.org/10.1002/ehf2.12432

Ejemplares similares